Please login to the form below

Not currently logged in
Email:
Password:

Sanofi Pasteur MSD

This page shows the latest Sanofi Pasteur MSD news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

As part of Sanofi Pasteur, we expect our Flublok influenza vaccine to benefit from Sanofi Pasteur's expertise in the field of influenza vaccines.". ... their Sanofi Pasteur MSD joint venture.

Latest news

More from news
Approximately 3 fully matching, plus 49 partially matching documents found.

Latest Intelligence

  • Going fully digital Going fully digital

    Sanofi Pasteur MSD previously required upwards of nine months to bring approved commercial content to market in many of its largest markets. ... Sanofi Pasteur MSD also projects overall efficiency gains of 17% in year one and 33% annually in years two

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • STEM Healthcare bolsters its EU5 team STEM Healthcare bolsters its EU5 team

    Enrique Cruz-Jentoft (pictured right) has joined the agency as its general manager for Spain following pharmaceutical industry experience gained from servingand MSD. ... Meanwhile, Joanna Troman (pictured left) moves to STEM as a project director

  • Dean Sowman joins Portland Health Dean Sowman joins Portland Health

    He joins Portland from MHP Communications, where his two-year stint saw him rise to a senior account manager role and included a secondment to Sanofi Pasteur MSD’s comms team.

  • David Khougazian appointed president of Sanofi Pasteur MSD David Khougazian appointed president of Sanofi Pasteur MSD

    Olivier Charmeil, president and CEO of Sanofi Pasteur, said: “Sanofi Pasteur MSD is a major player in the European vaccines market. ... His knowledge of European markets and external stakeholders will be a strong asset to grow Sanofi Pasteur MSD's

  • Claire Hay joins UK creative agency Cherry Claire Hay joins UK creative agency Cherry

    In her new role at Cherry she joins the agency's senior management team and will have leadership responsibility for a number of clients, including Novo Nordisk and Sanofi Pasteur MSD.

  • emotive expands its team emotive expands its team

    He has been delivering pitches and proposals since starting at the agency and previously worked as a medical writer at Sanofi Pasteur MSD.

More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Valid Insight

Valid Insight is an award-winning pharmaceutical global market access consultancy....

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics